Last month, the FDA gave its approval in the use of marijuana for proposed research studies to be conducted by MAPS (Multidisciplinary Association of Psychedelic Studies) aimed at treating individuals suffering with the debilitating effects of post-traumatic stress disorder (PTSD).
Read More:FDA Study Approval Brings Marijuana One Step Closer to Treating PTSD
